Verastem, Inc. (VSTM)
NASDAQ: VSTM · Real-Time Price · USD
8.94
-0.06 (-0.67%)
At close: Oct 8, 2025, 4:00 PM EDT
9.11
+0.17 (1.90%)
After-hours: Oct 8, 2025, 7:51 PM EDT
Verastem Market Cap
Verastem has a market cap or net worth of $550.21 million as of October 8, 2025. Its market cap has increased by 374.73% in one year.
Market Cap
550.21M
Enterprise Value
470.61M
1-Year Change
374.73%
Ranking
Category
Stock Price
$8.94
Market Cap Chart
Since January 27, 2012, Verastem's market cap has increased from $213.30M to $550.21M, an increase of 157.95%. That is a compound annual growth rate of 7.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 553.90M | 140.72% |
| Dec 31, 2024 | 230.10M | 11.86% |
| Dec 29, 2023 | 205.70M | 143.14% |
| Dec 30, 2022 | 84.60M | -77.35% |
| Dec 31, 2021 | 373.50M | 3.29% |
| Dec 31, 2020 | 361.60M | 263.05% |
| Dec 31, 2019 | 99.60M | -59.81% |
| Dec 31, 2018 | 247.80M | 99.36% |
| Dec 29, 2017 | 124.30M | 200.24% |
| Dec 30, 2016 | 41.40M | -39.74% |
| Dec 31, 2015 | 68.70M | -70.98% |
| Dec 31, 2014 | 236.70M | -19.05% |
| Dec 31, 2013 | 292.40M | 56.53% |
| Dec 31, 2012 | 186.80M | -12.42% |
| Jan 27, 2012 | 213.30M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.91B |
| Johnson & Johnson | 453.36B |
| AbbVie | 406.71B |
| UnitedHealth Group | 325.13B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.80B |